Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 trial
Dokumenttyp:
Zeitschriftenaufsatz
Autor(en):
Wick, A. ; Sander, A. ; Koch, M. ; Bendszus, M. ; Combs, S. ; Haut, T. ; Dormann, A. ; Walter, S. ; Pertz, M. ; Merkle-Lock, J. ; Selkrig, N. ; Limprecht, R. ; Baumann, L. ; Kieser, M. ; Sahm, F. ; Schlegel, U. ; Winkler, F. ; Platten, M. ; Wick, W. ; Kessler, T.
Stichworte:
Study Protocol ; Qualified overall survival (qOS) ; Neurocognition ; Procarbazine, CCNU, vincristine (PCV) ; CCNU and Temozolomide for Glioma (CETEG) ; Health-related quality of life (HRQoL) ; Oligodendroglioma ; Medical and Health Sciences
Login
BibTeX